|
| |
| Cat. No |
Model |
Description |
Unit |
Price
(VAT별도) |
납기 |
재고 |
DataSheet |
주문/견적 |
| LCA-50-11266 |
416358-1 |
Anti-8-Isoprostane, Sepharose™ Conjugated Column/20 ml column/ |
1/EA |
|
|
|
|
문의 |
|
|
|
|
|
|
|
Subject
|
Anti-8-Isoprostane, Sepharose™ Conjugated Column |
|
Description
|
20 ml column / |
|
Clonality
|
Poly |
|
Company
|
Cayman Chemical |
|
Application
|
Affinity purification |
|
Conjugation
|
|
|
Immunogen
|
8-Isoprostane |
|
Contents
|
Traditional purification of urine and plasma samples prior to measurement by EIA has required the use of reverse phase C-18 columns and various organic solvents. As this method relies upon polarity for separation, the final purified product is a non-specific mixture of many compounds. Further purification by TLC or HPLC is then required to isolate a single product. As an alternative, affinity chromatography provides a specific, reliable, and convenient means of purification for a variety of sample types. Cayman Chemical has developed an affinity column for the purification of 8-isoprostane (8-iso PGF2α) from urine and plasma samples. The affinity column can be regenerated by following a simple washing procedure. 8-Isoprostane is a potent pulmonary and renal vasoconstrictor and has been implicated as a causative mediator of hepatorenal syndrome and pulmonary oxygen toxicity. It has also been proposed as a marker of antioxidant activity. Cayman Chemical\'s 8-Isoprostane EIA Kit (Catalog No. 516351) is a highly sensitive and accurate assay, and our affinity purification reagents improve it even more. SEPHAROSE is a trademark of Ge Healthcare companies |
|
|
|
|
